ACA Health Insurance Premiums to Rise 75% as Pandemic Subsidies Expire
ACA marketplace premiums are set to increase by 75% after pandemic-era subsidies expire, risking higher uninsured rates and market instability.
Federal Drug Price Negotiations, Perverse Incentives, and Medicare Reforms
Analysis of federal drug price negotiations under the Inflation Reduction Act, examining perverse incentives in Medicare and private insurance, and exploring Medicare Advantage reforms to improve market efficiency and patient coverage.
Trump Administration to Reintroduce 'Most Favored Nation' Drug Pricing for Medicare
The Trump administration plans to reintroduce a 'most favored nation' drug pricing model for Medicare, aiming to align U.S. drug prices with lower international rates. This strategy faces industry opposition but could complement existing Medicare drug price negotiations to reduce costs.
NCOIL 2025 Spring Meeting Elevates National Insurance Policy Collaboration
The 2025 NCOIL Spring Meeting in Charleston advances key insurance reforms, including prior authorization, AI in insurance, and prescription drug affordability, with record participation from legislators and regulators.